Dec 17, 2019
China IND Approval Triggers $5 Million Milestone Payment From Everest Medicines
Dec 16, 2019
ANSYS to Join NASDAQ-100 Index
Dec 16, 2019
NeuroVive Announces Settlement in Dispute With CicloMulsion AG
Dec 11, 2019
LendingTree Introduces 2020 Guidance Ahead Of Investor Day
Dec 10, 2019
Applied DNA Sciences and Reliance Industries Sign MOU to Incorporate CertainT Forensic Traceability Into R|Elan Fabric and Recron GreenGold® Recycled Polyester Fiber and Filament
Dec 09, 2019
Doptelet ® (avatrombopag) Demonstrates Cost-effectiveness for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease
Dec 09, 2019
Additional Analyses From Phase 3 study With Doptelet ® (avatrombopag) for the treatment of Chronic Immune Thrombocytopenia Provides Evidence of Long-term Response Rates
Dec 05, 2019
Data to be Highlighted at the American Society of Hematology 2019 Annual Meeting
Dec 05, 2019
WiLAN Subsidiary and CXMT Enter into License and Acquisition Agreements
Dec 03, 2019
Quarterhill Announces U.S. Delisting and Deregistration
Dec 02, 2019
Blackbaud Celebrates GivingTuesday with Stories of Impact
Nov 26, 2019
Applied DNA Sciences Regains Compliance with Nasdaq Listing Standards
Nov 25, 2019
WiLAN Signs Wireless License with LG
Nov 22, 2019
NextDecade Receives FERC Order for Rio Grande LNG Project
Nov 20, 2019
Therapix Biosciences Announces Receipt of Notice of Delisting From Nasdaq and Intention to Appeal
Nov 19, 2019
Veoneer Joins Autonomous Vehicle Computing Consortium to Accelerate Development of Autonomous Vehicles
Nov 19, 2019
Why Oncology Drugs are Projected to Generate the Largest Pharma Revenues
Nov 18, 2019
WiLAN Settles Litigation with Canadian Service Providers
Nov 18, 2019
Cancer Drugs Poised to Improve as New Developments Help Previous Therapies Target Better
Nov 18, 2019
Spark Networks Appoints Eric Eichmann as Chief Executive Officer